![Magnus Hansson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Magnus Hansson
Teknisk/Vetenskaplig/F&U Direktör på
ABLIVA AB
Profil
Magnus Hansson is currently the Chief Medical Officer & VP-Preclinical Development at Abliva AB since 2016.
Previously, he worked as an Associate Professor at Skane University Hospital from 2008 to 2015.
Dr. Hansson obtained a doctorate degree from the University of Lund.
Aktiva positioner av Magnus Hansson
| Företag | Position | Start |
|---|---|---|
| ABLIVA AB | Teknisk/Vetenskaplig/F&U Direktör | 2016-01-01 |
Tidigare kända positioner av Magnus Hansson
| Företag | Position | Slut |
|---|---|---|
Skane University Hospital
 Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Företagsledare/Principal | 2015-12-01 |
Magnus Hanssons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
27
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Abliva AB
 Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Health Services |
